These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18767090)

  • 1. Crystallography-independent determination of ligand binding modes.
    Orts J; Tuma J; Reese M; Grimm SK; Monecke P; Bartoschek S; Schiffer A; Wendt KU; Griesinger C; Carlomagno T
    Angew Chem Int Ed Engl; 2008; 47(40):7736-40. PubMed ID: 18767090
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
    Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
    Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence-based protein kinase inhibition: applications for drug development.
    Wexler ID; Niv MY; Reuveni H
    Biotechniques; 2005 Oct; 39(4):575-6. PubMed ID: 16235571
    [No Abstract]   [Full Text] [Related]  

  • 4. Accounting for conformational variability in protein-ligand docking with NMR-guided rescoring.
    Skjærven L; Codutti L; Angelini A; Grimaldi M; Latek D; Monecke P; Dreyer MK; Carlomagno T
    J Am Chem Soc; 2013 Apr; 135(15):5819-27. PubMed ID: 23565800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases.
    Lavogina D; Lust M; Viil I; König N; Raidaru G; Rogozina J; Enkvist E; Uri A; Bossemeyer D
    J Med Chem; 2009 Jan; 52(2):308-21. PubMed ID: 19143565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple and single binding modes of fragment-like kinase inhibitors revealed by molecular modeling, residue type-selective protonation, and nuclear overhauser effects.
    Constantine KL; Mueller L; Metzler WJ; McDonnell PA; Todderud G; Goldfarb V; Fan Y; Newitt JA; Kiefer SE; Gao M; Tortolani D; Vaccaro W; Tokarski J
    J Med Chem; 2008 Oct; 51(19):6225-9. PubMed ID: 18771253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery.
    Ghose AK; Herbertz T; Pippin DA; Salvino JM; Mallamo JP
    J Med Chem; 2008 Sep; 51(17):5149-71. PubMed ID: 18710211
    [No Abstract]   [Full Text] [Related]  

  • 8. NMR characterization of kinase p38 dynamics in free and ligand-bound forms.
    Vogtherr M; Saxena K; Hoelder S; Grimme S; Betz M; Schieborr U; Pescatore B; Robin M; Delarbre L; Langer T; Wendt KU; Schwalbe H
    Angew Chem Int Ed Engl; 2006 Jan; 45(6):993-7. PubMed ID: 16374788
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystallography for protein kinase drug design: PKA and SRC case studies.
    Breitenlechner CB; Bossemeyer D; Engh RA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):38-49. PubMed ID: 16269279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of spin diffusion methods for the determination of protein-ligand complex structural ensembles.
    Pilger J; Mazur A; Monecke P; Schreuder H; Elshorst B; Bartoschek S; Langer T; Schiffer A; Krimm I; Wegstroth M; Lee D; Hessler G; Wendt KU; Becker S; Griesinger C
    Angew Chem Int Ed Engl; 2015 May; 54(22):6511-5. PubMed ID: 25877959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzothiophene inhibitors of MK2. Part 2: improvements in kinase selectivity and cell potency.
    Anderson DR; Meyers MJ; Kurumbail RG; Caspers N; Poda GI; Long SA; Pierce BS; Mahoney MW; Mourey RJ; Parikh MD
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4882-4. PubMed ID: 19616942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-state NMR spectroscopy as a tool for drug design: from membrane-embedded targets to amyloid fibrils.
    Middleton DA
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):985-90. PubMed ID: 17956260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, selection, and evaluation of a general kinase-focused library.
    Decornez H; Gulyás-Forró A; Papp A; Szabó M; Sármay G; Hajdú I; Cseh S; Dormán G; Kitchen DB
    ChemMedChem; 2009 Aug; 4(8):1273-8. PubMed ID: 19551802
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of death-associated protein kinases inhibitors using structure-based virtual screening.
    Okamoto M; Takayama K; Shimizu T; Ishida K; Takahashi O; Furuya T
    J Med Chem; 2009 Nov; 52(22):7323-7. PubMed ID: 19877644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Halogen bonding--a novel interaction for rational drug design?
    Lu Y; Shi T; Wang Y; Yang H; Yan X; Luo X; Jiang H; Zhu W
    J Med Chem; 2009 May; 52(9):2854-62. PubMed ID: 19358610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Crystallography-based drug design].
    Matsuzaki T
    Tanpakushitsu Kakusan Koso; 2005 Jun; 50(7):869-75. PubMed ID: 15957411
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
    Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does a fast nuclear magnetic resonance spectroscopy- and X-ray crystallography hybrid approach provide reliable structural information of ligand-protein complexes? A case study of metalloproteinases.
    Isaksson J; Nyström S; Derbyshire D; Wallberg H; Agback T; Kovacs H; Bertini I; Giachetti A; Luchinat C
    J Med Chem; 2009 Mar; 52(6):1712-22. PubMed ID: 19239231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
    Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
    ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rank-ordering protein-ligand binding affinity by a quantum mechanics/molecular mechanics/Poisson-Boltzmann-surface area model.
    Wang M; Wong CF
    J Chem Phys; 2007 Jan; 126(2):026101. PubMed ID: 17228977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.